Vetrax-TZ 1.125 Injection
Marketer
Vee Remedies
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Vetrax-TZ 1.125 Injection
Combiflox-TZ 1.125 Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby containing infection spread. Administration must be under a healthcare provider's direct guidance; adhere strictly to the prescribed schedule. Complete the full course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before use. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutritious food, and sufficient hydration promote optimal recovery. Monitoring may involve laboratory tests to assess therapeutic response.
Uses of Vetrax-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Vetrax-TZ 1.125 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vetrax-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Vetrax-TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vetrax-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, the components of Vetrax-TZ 1.125 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thus inhibiting bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, bolstering Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Vetrax-TZ 1.125 Injection does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vetrax-TZ 1.125 is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Vetrax-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Vetrax-TZ 1.125 Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Vetrax-TZ 1.125 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Vetrax-TZ 1.125 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Vetrax-TZ 1.125 Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vetrax-TZ 1.125 Injection :
Should you forget a scheduled Vetrax-TZ 1.125 Injection, seek your physician's advice.
Facts to Know About Vetrax-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently